- Report
- May 2024
- 184 Pages
Global
From €3210EUR$3,374USD£2,749GBP
€3567EUR$3,749USD£3,054GBP
- Report
- September 2023
- 145 Pages
Global
From €5661EUR$5,950USD£4,847GBP
- Report
- May 2024
- 197 Pages
Global
From €4710EUR$4,950USD£4,033GBP
- Report
- May 2024
- 244 Pages
Global
From €5185EUR$5,450USD£4,440GBP
- Report
- June 2023
- 65 Pages
Global
From €4710EUR$4,950USD£4,033GBP
- Report
- April 2024
- 135 Pages
Global
From €3710EUR$3,899USD£3,176GBP
- Report
- January 2024
- 200 Pages
Global
From €4757EUR$5,000USD£4,073GBP
- Report
- December 2023
- 200 Pages
Global
From €4757EUR$5,000USD£4,073GBP
- Report
- December 2023
- 200 Pages
Global
From €4757EUR$5,000USD£4,073GBP
- Report
- November 2023
- 250 Pages
Global
From €4757EUR$5,000USD£4,073GBP
- Report
- May 2023
- 134 Pages
Global
From €2378EUR$2,499USD£2,036GBP
- Report
- February 2024
- 174 Pages
Global
From €4662EUR$4,900USD£3,992GBP
- Report
- February 2024
- 186 Pages
Global
From €4662EUR$4,900USD£3,992GBP
- Report
- January 2024
- 150 Pages
Global
From €4615EUR$4,850USD£3,951GBP
- Report
- February 2024
- 179 Pages
Global
From €4519EUR$4,750USD£3,870GBP
- Report
- November 2023
- 178 Pages
Global
From €4662EUR$4,900USD£3,992GBP
- Report
- October 2023
- 190 Pages
Global
From €4662EUR$4,900USD£3,992GBP
- Report
- October 2023
- 172 Pages
Global
From €4662EUR$4,900USD£3,992GBP
- Report
- November 2023
- 161 Pages
Global
From €2379EUR$2,500USD£2,037GBP
- Report
- January 2024
- 175 Pages
Global
From €4662EUR$4,900USD£3,992GBP
Single Use Bioreactors (SUBs) are bioreactors that are designed for a single use and then disposed of. They are used in biotechnology for the production of biopharmaceuticals, such as vaccines, monoclonal antibodies, and recombinant proteins. SUBs are typically made of plastic and are pre-sterilized, eliminating the need for cleaning and sterilization between batches. This makes them ideal for rapid scale-up and production of biopharmaceuticals. SUBs also offer advantages such as reduced risk of contamination, improved process control, and reduced capital costs.
The SUB market is growing rapidly due to the increasing demand for biopharmaceuticals and the need for rapid scale-up and production. SUBs are becoming increasingly popular in the biotechnology industry due to their cost-effectiveness and convenience.
Some companies in the SUB market include Sartorius, Thermo Fisher Scientific, Merck KGaA, GE Healthcare, and Pall Corporation. Show Less Read more